PR NewswireHOBOKEN, N.J., April 16, 2025
Dr. Yuping Huang Named Interim CEO and PresidentHOBOKEN, N.J., April 16, 2025 /PRNewswire/ -- Quantum Computing In
\n\nPR NewswireCLEVELAND, April 16, 2025\n\n\n\nRobert J. Gamgort, Executive Chairman of Keurig Dr Pepper Inc., joins the BoardCLEVELAND, April 16, 2025 /PRNewswire/
\n Cardiol Therapeutics (CRDL) has commenced its pivotal Phase III MAVERIC trial with the enrollment of the first patient. The trial will assess the effica
Omeros Corporation (Nasdaq: OMER) today announced the establishment of the Omeros Oncology Clinical Steering Committee to advance Omeros' OncotoX biologics pro
ROSEMONT, Ill., March 27, 2025 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation ( WTFC) today announced Amy Yuhn has been named Executive Vice President for
NEW YORK (Reuters) -Global stocks dropped for the first time in three sessions on Wednesday and the U.S. dollar resumed its ascent as investors awaited the next tariff announcement from U.S. President Donald Trump. Trump was scheduled to hold a press conference at 4 p.m. EDT (2000 GMT) and has recently confirmed the auto tariffs will be on cars. Stocks had shown signs of bottoming in recent days after coming under pressure due to uncertainty over the tariff outlook and its potential to slow the global economy and dent corporate profits.
Almonty Industries Inc. (”Almonty” or the ”Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI), a leading global producer of tungsten conce
TORONTO — Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI), a leading global producer of tungsten concent…
[url="]Veracyte, Inc[/url]. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced that multiple abstracts will be presented at the 40th Annual
[url="]PureTech Health plc[/url] (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded Enti
Experts say the trades likely don’t violate insider trading laws, but the timing raises concerns if the directors acted in the company’s best interests.
Also in the Forbes CFO newsletter: Wide response to new import duties, Treasury modifies reporting under CTA, unexpected critics for Trump’s crypto reserve.